DOI QR코드

DOI QR Code

Epidemiological Aspects of Morbidity and Mortality from Cervical Cancer in Kazakhstan

  • Published : 2012.05.30

Abstract

Epidemiological studies of cancer incidence in Kazakhstan have revealed an uneven distribution for cervical cancer. Incidence and mortality rates were calculated for different regions of the republic, including the two major cities of Almaty and Astana, in 1999-2008. Defined levels for cartograms for incidence were low (up to 12.8/100,000), medium (12.8 to 15.9) and high (above 15.9) and for mortality were up to 7.1, 7.1 to 10.8 and more than 10.8, respectively. Basically high incidence rates were identified in the eastern, central and northern parts of the country and in Almaty. Such differences in cervical cancer data, and also variation in mortality/ incidence ratios, from a low of 0.4 in Almaty to a high of 0.71 in Zhambyl, point to variation in demographic and medical features which impact on risk and prognistic factors for cervical cancer in the country. Further research is necessary to highlight areas for emphasis in cancer control programs for this important cancer.

Keywords

References

  1. American Cancer Society (2012). Cancer facts and figures 2012, American Cancer Society, Atlanta. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf
  2. Cheng EM, Atkinson PM, Shahani AK (2011). Elucidating the spatially varying relation between cervical cancer and socioeconomic conditions in England. Int J Health Geogr, 10, 51. https://doi.org/10.1186/1476-072X-10-51
  3. Davydov MI, Aksel' EM (2007). The incidence of malignant tumors and mortality caused by them in Commonwealth of Independent States in 2005. Vestn Ross Akad Med Nauk, 11, 45-9 ( in Russian).
  4. Demography Yearbook of Kazakhstan regions (2007). Statistical handbook. Astana, 392 p.
  5. Demography Yearbook of Kazakhstan regions (2010). Statistical handbook. Astana, 637 p.
  6. Domingo EJ, Noviani R, Noor MR, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26 Suppl 12, M71-9. https://doi.org/10.1016/j.vaccine.2008.05.039
  7. Esmaeili M, Bonyadi M, Dastranj A, et al (2008). HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest, 66, 68-72. https://doi.org/10.1159/000134917
  8. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 7.5.2012.
  9. Ghaffari SR, Sabokbar T, Mollahajian H, et al (2006). Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev, 7, 529-32.
  10. Glantz S (1999). Medical-biological statistics. Monograph, Moscow, 460 pp.
  11. Hamkar R, Azad TM, Mahmoodi M, et al (2002). Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J, 8, 805-11.
  12. Hanson KP (2002). Modern understanding of carcinogenesis of cervical cancer. Practical Oncology, 3, 3.
  13. Igisinov N (2004). Ethnic and age variation of cancer of the reproductive system in women of Kyrgyzstan. Asian Pac J Cancer Prev, 5, 217-22.
  14. Igissinov N, Igissinov S, Moore MA, et al (2011). Trends of prevalent cancer incidences in the Aral-Syr Darya ecological area of Kazakhstan. Asian Pac J Cancer Prev, 12, 2299-303.
  15. Igissinov N, Tereshkevich D, Moore MA, et al (2011b). Age characteristics of incidences of prevalent cancers in the Aral Sea area of Kazakhstan. Asian Pac J Cancer Prev, 12, 2295-7.
  16. Igissinov S (1974). Method of preparation and use of maps in oncology practice. Zdravookhranenie Kazakhstana, 2, 69-71.
  17. Kulmala SM, Shabalova IP, Petrovitchev N, et al (2007). Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol, 79, 771-81. https://doi.org/10.1002/jmv.20839
  18. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011). Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer, 128, 927-35. https://doi.org/10.1002/ijc.25396
  19. Lorenzo-Luaces Alvarez P, Guerra-Yi ME, Faes C, Galan Alvarez Y, Molenberghs G (2009). Spatial analysis of breast and cervical cancer incidence in small geographical areas in Cuba, 1999-2003. Eur J Cancer Prev, 18, 395-403. https://doi.org/10.1097/CEJ.0b013e32832f9b93
  20. MEPs against cancer (2011). Cancer facts and figures. Available from: http://www.mepsagainstcancer.org
  21. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11 Suppl 2, 17-32.
  22. Moore MA, Aitmurzaeva G, Arsykulov ZA, et al (2009). Chronic disease prevention research in Central Asia, the Urals, Siberia and Mongolia - past, present and future. Asian Pac J Cancer Prev, 10, 987-96.
  23. Moore MA, Sobue (2010). Strategies for cancer control on an organ-site basis. Asian Pac J Cancer Prev, 11 Suppl 2, 149-64.
  24. Ondrusova M, Zubor P, Ondrus D (2012). Time trends in cervical cancer epidemiology in the Slovak Republic: reflection on the non-implementation of screening with international comparisons. Neoplasma, 59, 121-8. https://doi.org/10.4149/neo_2012_016
  25. Ozcelik B, Serin IS, Gokahmetoglu S, Basbug M, Erez R (2003). Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol, 24, 157- 9.
  26. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  27. Roder D, Currow D (2009). Cancer in Aboriginal and Torres Strait Islander People of Australia. Asian Pac J Cancer Prev, 10, 729-34.
  28. Soto-De Leon S, Camargo M, Sanchez R, et al (2011). Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One, 6, e14705. https://doi.org/10.1371/journal.pone.0014705
  29. Ting J, Kruzikas DT, Smith JS (2010). A global review of agespecific and overall prevalence of cervical lesions. Int J Gynecol Cancer, 20, 1244-9. https://doi.org/10.1111/IGC.0b013e3181f16c5f
  30. Ushakov IB, Volodin AS, Chikova SS, Zueva TV (2005). Medical aspects of human health protection from the deleterious influence of environmental factors. Gig Sanit, 6, 29-34.
  31. van der Aa MA, Siesling S, Louwman MW, et al (2008). Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989-2003. Eur J Cancer Prev, 17, 453-9. https://doi.org/10.1097/CEJ.0b013e3282f75ed0
  32. Walters S, Quaresma M, Coleman MP, et al (2011). Geographical variation in cancer survival in England, 1991-2006: an analysis by Cancer Network. J Epidemiol Community Health, 65, 1044-52. https://doi.org/10.1136/jech.2010.126656
  33. World Health Organization Statistical information System (2011). WHO mortality database. Available from: http://www3.who.int/whosis/whosis/menu.cfm.

Cited by

  1. Laryngeal Cancer in Kazakhstan - Ethnic, Age and Gender Differences over Time vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.7033
  2. Epidemiological Evaluation of Laryngeal Cancer Incidence in Kazakhstan for The Years 1999-2009 vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3969
  3. Overview of Cancer Registration Research in the Asian Pacific from 2008-2013 vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4461
  4. Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012 vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6969
  5. Cancer Incidence and Mortality Data in Aktobe, West Kazakhstan, 2000-2010 vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2379